INS and metabolic dysfunction-associated steatohepatitis: The greater magnitude of resistance to the anti-lipolytic effect of insulin in SAT (sixfold vs. controls) in comparison to whole-body adipose (threefold vs. controls) in our study may well reflect depot-specific IR, in which abdominal SAT is the major source of lipotoxicity in NASH.